This article was originally published on Medtech Intelligence. This article is a continuation of the two-part series on the hospital sector in Asia. Last month’s article focused on China’s hospital growth. This month’s article will expand on the status and prospects of... Read More
Under popular pressure to boost the affordability of cancer medications, China’s health insurance regulator announced in August that it will add a range of cancer drugs to the list of those already covered by the national medical insurance system. At the same... Read More
This article was originally published on Medtech Intelligence. Hospitals in key Asian countries are enjoying strong growth prospects, spurred by aging populations, a rising middle class, an expansion of public health insurance, and the encouragement of private and foreign investment in the... Read More
The market in India for in vitro diagnostics (IVDs)—the simple but effective laboratory tests on tissue samples used to detect diseases, conditions, and infections—is growing by a rapid 8.6% annually, according to a report from The Business Research Company. India’s IVD market... Read More
One year after Singapore launched an initiative to establish itself as a regional leader for artificial intelligence (AI) research and entrepreneurship, the city-state is well on its way to harnessing the power of intelligent computing to tackle some of its most pressing... Read More
Flush with cash and eager to gain earlier and easier access to innovative drug technologies, Chinese investors have been pumping money into Western biotech startups over the past two years. But despite this recent trend, U.S. President Donald Trump’s plan to limit... Read More
More than 450 million Chinese—one in three people in the world’s most populous country—suffer from nearsightedness, according to statistics released by China’s National Health Commission in June. Sixty years ago, 10%-20% of the Chinese population was short-sighted. Today, one third—including a startling... Read More
In May, the Chinese government published its first national list of rare diseases, a welcome development for foreign pharmaceutical companies eager to market treatments for their products there. The list of 121 diseases identified as rare was published by five Chinese government... Read More
Chronic obstructive pulmonary disease (COPD) is more prevalent in China than anywhere else in the world, afflicting more than 8.6% of adults, according to a new study by researchers at Tulane University. Almost 100 million people in China suffer from the group... Read More
Seeking to bolster its artificial intelligence (AI) industry in the face of foreign competition, South Korea has announced plans to invest $2 billion over three years in the development of thinking computer systems. Among the research priorities outlined by Korea’s science ministry... Read More